TrialThe Journal of allergy and clinical immunology2025

CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity.

H Mark Kenney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.